Inventor
Bhujanga Rao Adibhatla Kali Satya
Inventor
Hyderabad, IN
Overview
Patents· 16 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds32%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
A61KPreparations for medical, dental or toiletry purposes19%
C07CAcyclic or carbocyclic compounds9%
C07BGeneral methods of organic chemistry4%
C07KPeptides2%
C08GMacromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds2%
Y02PClimate change mitigation technologies in the production or processing of goods2%
PatentTitleYear
9,481,655'6,7-dialkoxy quinazoline derivatives and methods of treating drug resistant and other tumors'20168,993,722'Process for the preparation glatiramer acetate (copolymer-1)'20158,921,362'6,7-dialkoxy quinazoline derivatives and methods of treating drug resistant and other tumors'20148,748,602'Polymorphs of erlotinib hydrochloride and method of preparation'20148,735,415'Acid addition salts of (3,5-Bis trifluoromethyl)-N-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2ylamino)-phenyl]-benzamide'20148,664,389'Process for the preparation of lapatinib and it\'s pharmaceutically acceptable salts'20148,501,962'Process for the preparation of high purity sunitinib and its pharmaceutically acceptable salt'20138,466,190'Polymorphic forms of Sunitinib base'20138,349,855'Polymorphs of erlotinib hydrochloride and method of preparation'20138,183,253'Phenylaminopyrimidine derivatives as inhibitors of bcr-abl kinase'20128,143,250'6-7,dialkoxy quinazoline derivatives useful for treatment of cancer related disorders'20128,080,558'4-(tetrazol-5-yl)-quinazoline derivatives as anti-cancer agent'20118,067,422'Crystal form of phenylamino pyrimidine derivatives'20118,048,883'Polymorphic form of imatinib mesylate and a process for its preparation'20117,939,541'Intermediates and a process employing the intermediates for the preparation of (3-trifluoromethylsulfonyl)-N-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2ylamino)-phenyl]-benzamide'20117,910,598'Phenylaminopyrimidine derivatives as inhibitors of BCR-ABL kinase'2011Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2011–2016Patents assigned to NATCO PHARMA LTD (16)· patent assignee history
2011–2015Patents assigned to ADIBHATLA KALI SATYA BHUJANGA RAO (11)· patent assignee history
2011–2015Patents assigned to VENKAIAH CHOWDARY NANNAPANENI (10)· patent assignee history
2011–2014Patents assigned to KOMPELLA AMALA KISHAN (3)· patent assignee history
2011–2015Based in Hyderabad, IN· patent location history
2012–2014Patents assigned to JYOTHI PRASAD RAMANADHAM (4)· patent assignee history
2014–2016Based in Andhra Pradesh, IN· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NATCO PHARMA LTD | 16 | 2011–2016 |
| ADIBHATLA KALI SATYA BHUJANGA RAOself | 11 | 2011–2015 |
| VENKAIAH CHOWDARY NANNAPANENI | 10 | 2011–2015 |
| JYOTHI PRASAD RAMANADHAM | 4 | 2012–2014 |
| KOMPELLA AMALA KISHAN | 3 | 2011–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Hyderabad, IN | 13 | 2011–2015 |
| Andhra Pradesh, IN | 3 | 2014–2016 |